Article Information
History
- July 26, 2024.
Article Versions
- You are currently viewing Version 1 of this article (July 26, 2024 - 07:34).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- J. Oscanoa1,a,
- H Ross-Adams1,a,
- Abu Z M Dayem Ullah1,2,
- TS Kolvekar1,2,
- L Sivapalan1,
- E Gadaleta1,
- GJ Thorn1,
- M Abdollahyan1,
- A Imrali2,
- A Saad2,4,
- R Roberts2,
- C Hughes2,
- PCRFTB,
- HM Kocher2,3,4 and
- C Chelala1,2,*
- 1Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University London, UK, EC1M 6BQ
- 2Pancreatic Cancer Research Fund Tissue Bank, Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University London, UK, EC1M 6BQ
- 3Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University London, UK, EC1M 6BQ
- 4Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, Whitechapel, London E1 1BB
- ↵*Corresponding Author: Prof C Chelala, c.chelala{at}qmul.ac.uk
↵a These authors contributed equally.